“Intravesical BCG Immunotherapy for Non-Muscle Invasive Bladder Cancer During COVID-19 Pandemic: Mutual Impact and Implications”. Chemical Biology Letters, vol. 9, no. 2, Feb. 2022, p. 267, https://pubs.thesciencein.org/journal/index.php/cbl/article/view/267.